As global leaders convene at COP29 to address climate change, with health emerging as a key theme, a new study published in Clinical Ophthalmology underscores the pressing intersection between environmental factors and public health. The research highlights a significant link between air pollution and eye health issues, emphasizing the urgent need for action to mitigate these impacts.
The American Academy of Ophthalmology (AAO) 2024 meeting in Chicago showcased many advancements in retinal research that show promise for the future.
Researchers and clinicians making significant strides in how eye conditions are treated and managed. From improving drug delivery methods to harnessing the potential of gene and stem cell therapies, 2024 has been a year of promising progress across multiple areas. As we edge closer to 2025, we are eager to see what advancements will further improve vision and eye care.
The World Glaucoma Association (WGA) is thrilled to announce the 11th World Glaucoma Congress, scheduled for June 25-28, 2025, in Honolulu, Hawaii, USA. Held biennially, the WGC is the largest international meeting dedicated to glaucoma, providing a platform for young researchers to present their work and gain recognition within the global glaucoma community.
Education, Conference Coverage and Articles
The uvea is a vascular stratum that includes the iris, ciliary body and choroid. Uveitis is defined as inflammation of a part of the uvea or its entirety, but it is also used to describe inflammatory processes of any part ...
Thermoreceptors on the ocular surface play a critical role in the development of dry eye disease (DED). An experimental eye drop called AR-15512, which activates cooling receptors, has been found to provide fast and continuous relief from dry eye symptoms, ...
In our latest episode, we explore the pioneering work of Guy Kezirian, MD, a world-renowned visionary in ophthalmology and refractive surgery. Through fellow refractive surgeon Dr. Jennifer Loh, we learn how Dr. Kizerian’s mindset and innovations revolutionized the field and how his unique blend of medical expertise and entrepreneurial spirit has led to breakthroughs beyond the operating room.
We are pleased to present the latest edition of touchREVIEWS in Ophthalmology. In this issue, we offer a series of engaging editorials, in-depth review articles and insightful original research highlighting some of the latest breakthroughs, innovations and practical insights in ...
Share your knowledge, influence clinical practices and enhance patient care in Ophthalmology today!
Age-related macular degeneration (AMD) is a chronic deterioration and dysfunction of the outer retinal tissue and Bruch’s membrane (BrM). It is the leading cause of vision loss in people older than 60 years and is estimated to affect 288 million people ...
Dry eye disease (DED) is a prevalent ocular condition characterized by discomfort, visual disturbances and tear film instability due to insufficient tear production or rapid tear evaporation.1 With an increasing global incidence (i.e. up to 50%) and its significant impact ...
Thyroid eye disease (TED) is an autoimmune condition that can lead to significant visual impairment, facial disfigurement and decreased quality of life. It affects 16 out of every 100,000 females and 2.9 out of every 100,000 males. Risk factors for TED include age, female ...
Contrast sensitivity (CS), which is an important element of functional vision, helps in differentiating an object from its background. CS affects several aspects of vision, such as acuity, dark adaptation, visual field, motion detection and pattern recognition.1 A decline in ...
The demands for refractive surgery weigh on achieving the best unaided vision postoperatively. This, in many clinics, lines up with achieving a plano or minimal spherocylindrical manifest refraction. However, in my experience, many patients are complaining of blurred vision after ...
Neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DME) are two leading causes of visual impairment and blindness in the USA.1,2 Faricimab is the first bispecific antibody approved by the US Food and Drug Administration in ophthalmology and was ...
The accumulation of transudative fluid in the suprachoroidal space, known as choroidal effusion, is a prevalent and often asymptomatic complication of glaucoma surgery. Choroidal effusions have also been linked with other aetiologies, including infections, inflammatory diseases, medications and other ocular ...
Recent advancements in publicly available artificial intelligence (AI) large language models (LLMs) have piqued the interest of the medical community. LLMs are 'trained' using massive datasets and can generate natural language text in response to free-text inputs. Conversational agents (chatbots), ...
Age-related macular degeneration (AMD) is one of the main causes of irreversible vision loss in ageing populations worldwide.1 In 2019, the US recorded 1.49 million people aged 40 years or older with late-stage AMD, reflecting a crude prevalence rate of 0.94%.2 Geographic atrophy (GA), ...
Welcome to the latest edition of touchREVIEWS in Ophthalmology, and my first as the journal’s Editor-in-Chief. In this issue, we are delighted to present a series of compelling articles providing insights into some of the cutting-edge developments in this ...
Retinal pharmacotherapy encompasses various drug delivery routes that offer potential avenues for effective treatment (Figure 1). Among these, intravitreal injections have emerged as the predominant method employed in clinical practice.1 They have established themselves as the primary approach for administering anti-vascular ...
Age-related macular degeneration (AMD) is a progressive eye condition that affects millions of people worldwide and poses a significant threat to vision in individuals over the age of 50.1 Of the two types of AMD, wet AMD, which is characterized by ...
Introducing the Editorial Board of touchREVIEWS in Ophthalmology, who support our mission to advance medical knowledge and practice by ensuring the integrity, relevance, and impact of the content we publish. Together, we strive to foster a vibrant academic community and contribute to the continuous improvement of healthcare worldwide.
Cataract
Ophthalmologist, Miami, FL, USA
Jennifer Loh, MD is a board-certified ophthalmologist practising in Miami, Florida with a focus on cataract-refractive surgery and dry eye disease. She is founder and medical director of her practice, Loh Ophthalmology Associates, which she started in 2016. Dr Loh also spends her time as a clinical and surgical attending for the Larkin Hospital Ophthalmology Residency program. She is a graduate of Indiana University School of Medicine, where she completed both medical school and ophthalmology residency. On a personal note, Dr Loh enjoys skiing and travelling the world with her husband and son.
Retina
Professor and Chairman Department of Ophthalmology , University Vita-Salute, San Raffaele Scientific Institute, Milan, Italy
Francesco Bandello is Professor and Chairman at the Department of Ophthalmology University Vita-Salute, Scientific Institute San Raffaele, Milan, Italy. He is Past President Academic Dean of “Corso di Laurea Specialistica/Magistrale in Medicina e Chirurgia” at the same University. Professor Bandello is President of the Association of Italian University Professors of Ophthalmology (CONPROSO), President of ESASO Foundation (European School for Advanced Studies in Ophthalmology), President of Academia Ophthalmologica Europea, Vice President of EuroLam and Past President of EURETINA.
Prof. Bandello is Editor-in Chief of the European Journal of Ophthalmology, Active Member of The American Ophthalmological Society (AOS), Board Member of the Commission of prevention of blindness and low vision (Italian Ministry of Health), Executive Board Member of SISO (Società Italiana Scienze Oftalmologiche), Member of the Academia Ophthalmologica Internationalis and Member of the “Academia Nazionale di Medicina”.
Prof. Bandello is former Member of the Board of Directors of Club Jules Gonin and former Executive Committee Member of the Macula Society.
Prof. Bandello is co-author of 14 books and he served as a peer reviewer for grant applications for the NEI. He has authored or co-authored 1.087 Pub-Med articles and he served as trained Principal Investigator in several clinical trials performed following ICH/GCP and mainly concerning retinal diseases.
Anterior segment
Clinical Professor, University of California, San Francisco, CA, USA
David F Chang, MD is a Summa Cum Laude graduate of Harvard College and Harvard Medical School. He completed his ophthalmology residency at the University of California, San Francisco where he is now a clinical professor Dr Chang is clinical professor at the University of California, San Francisco and in private practice in Los Altos, CA. He previously chaired the ASCRS Cataract Clinical Committee and served on the ASCRS executive committee from 2009-2023. Dr Chang was the ASCRS president from 2012-2013, EyeWorld Chief Medical Editor from 2011-2015, and ASCRS Foundation chair from 2015-2023. With a strong interest in global cataract blindness, he received the 2019 AAO Humanitarian Service Award and the 2020 Aravind Venkataswamy Award. Dr Chang is co-founder and the advisory board chair of EyeSustain, a global consortium of eye societies advancing sustainability in ophthalmology. He is a past chair of the AAO Cataract Preferred Practice Pattern Panel and the AAO Annual Meeting Program Committee.
Dr Chang has been honored by the following international societies: AAO (Kelman Lecture), ASCRS (Binkhorst Medal), ESCRS (Ridley Medal), APACRS (Lim Medal), United Kingdom and Ireland Society of Cataract & Refractive Surgery (Rayner Medal), Canadian Society of Cataract and Refractive Surgery (Award of Excellence/Stein Lecture), All India Ophthalmology Society (President’s Lecture), Italian Ophthalmological Society (Strampelli Medal), International Intraocular Implant Club (IIIC Medal), AECOS (Visionary Award), DOC-German Ophthalmic Surgeons (DOC Innovator Lecture), International Society of Refractive Surgery (Presidential Award), RANZCO (Gregg Medal), APAO (Jose Rizal International Medal), MEACO (El-Maghraby International Award), and the ICO (T. Krwawicz Gold Medal).
Ocular Surface Disease
Professor of Clinical Ophthalmology and Director of Cornea, Refractive & Cataract Surgery at the Gavin Herbert Eye Institute, University of California-Irvine, CA, USA
Dr Marjan Farid is Professor of Clinical Ophthalmology and Director of Cornea, Refractive & Cataract Surgery at the Gavin Herbert Eye Institute, University of California-Irvine. She graduated Summa Cum Laude from UCLA with a degree in Biology and earned her medical degree at UC San Diego. Her clinical practice is divided between patient care, teaching and research. Her research interests focus on corneal surgery, specifically the use of the femtosecond laser for corneal transplantation. She is also the founder of the Severe Ocular Surface Disease Center at UCI and is a centre of excellence as part of the Holland Foundation for Sight Restoration. She performs Limbal Stem Cell transplants as well as artificial corneal transplantation for the treatment of patients with severe ocular surface disease. She currently serves as the Chair of the Cornea Clinical Committee of ASCRS. Her work is published in numerous peer-reviewed journals. She has authored multiple textbook chapters and travels extensively to present her work at national and international meetings.
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Register for free to hear about the latest expert-led education, peer-reviewed articles, conference highlights, and innovative CME activities.
Or use a Social Account.
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.